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An implantable system for delivering fluids, such as drugs,
to one or more anatomical structures in a patient' s (i. e .,

human or animal) body . A number of medical conditions
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require continual and /or periodic administration of fluids

( e .g ., drugs) to target regions (e . g ., anatomic organs) of the
body . Accessibility to those target regions might be limited
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technically for ex . and not limited to : frequent endoscopic ,
radiologically guided or surgical approaches. The system
delivers the fluid needed in a continual or intermittent
fashion to the target region . It controls the amount of fluid
delivered to the target region and measures the intended
physiologic effect of the fluid delivered .
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IMPLANTABLE FLUID DELIVERY SYSTEM
[0001] This is a new international application under the
Patent Cooperation Treaty (PCT).

TECHNICAL FIELD
[0002 ] The present invention is generally related to
implantable medical devices and , more particularly , to an
implantable system for delivering fluids, such as drugs, to
one or more anatomical structures in a patient's (i.e ., human
or animal) body .

BACKGROUND
[0003 ] A number of medical conditions require continual
and / or periodic administration of fluids (e .g., drugs) to target

regions ( e. g ., anatomical structures) of the body. A variety of
implantable fluid delivery devices/ systems are known and
generally include a port having a reservoir with a catheter
attached thereto . Fluid in the reservoir of the implanted port
is pumped by one or more pumps through the catheter and

to the target region ( s ) of the body. The port is implanted

beneath the skin of the patient and may include a septum that
is penetrable by a hypodermic needle . Thus , conventional
injections of a medication into a patient having an implanted
port are made by inserting a needle through the patient 's skin
and through the septum in the port . Fluid is injected through
the needle and into the reservoir of the port where it passes

into the catheter and eventually out to the target region (s ).
BRIEF DESCRIPTION OF THE DRAWINGS
[0004 ] One or more embodiments of the invention will

hereinafter be described in conjunction with the appended

drawings , wherein like designations denote the same or

similar elements, and wherein :
[0005 ] FIG . 1 is a diagrammatic view of an illustrative
embodiment of a fluid delivery system ;
10006 ] FIG . 2 is an isometric view of an illustrative

embodiment of a port of the fluid delivery system illustrated

in FIG . 1 ;

[0007 ] FIG . 3 is an isometric cross section view of the port

illustrated in FIG . 2 , taken along the lines 3 - 3 in FIG . 2 ;
0008 ]. FIG . 4 is an isometric view of another illustrative
embodimentof a port of the fluid delivery system illustrated
in FIG . 1 ;

[0009] FIG . 5 is a side elevation view of the port illus
trated in FIG . 4 ;
[0010 ] FIG . 6 is an isometric view of a first or top portion
of the port illustrated in FIG . 4 ;
[0011 ] FIG . 7 is a top plan view of the port illustrated in

FIG . 4 ;
[ 0012 ] FIG . 8 is an isometric view of an illustrative

embodiment of a bottom or base portion of the ports
[0013] FIG . 9 is an isometric view of a portion of an

illustrated in FIGS . 2 and 4 ;

illustrative embodiment of a catheter of the fluid delivery
system illustrated in FIG . 1;

Apr. 26 , 2018
of the fluid delivery system illustrated in FIG . 1 , with the

needle assembly thereof in a retracted state and a deployed
state , respectively ;

10016 ] FIGS . 12a and 12b are diagrammatic and side

elevation views of yet another illustrative embodiment of a
pod of the fluid delivery system illustrated in FIG . 1, with
the needle assembly thereof in a retracted state and a
deployed state, respectively ;
[0017 ] FIG . 13 is a diagrammatic view showing an
example of the fluid flow through a pod of the system
illustrated in FIG . 1;
[0018 ] FIG . 14 is a diagrammatic and schematic view of
an illustrative arrangement of a plurality of pods of the

system illustrated in FIG . 1 ; and

100191 FIG . 15 is a diagrammatic and schematic view of

an illustrative way of measuring the impedance of an

anatomical structure using an arrangement of pods of the
system illustrated in FIG . 1 .

DETAILED DESCRIPTION OF ILLUSTRATED

EMBODIMENT(S )
[0020 ] The description below pertains to an implantable

fluid delivery system that includes a port, for example, a port
a fluid , generally a drug , to one or more implantable pods

thatmay be implanted subcutaneously , configured to deliver

located or disposed at or on one or more target anatomical
structures ( e .g ., pylorus , bladder, etc .). An example of a fluid

that may be delivered using the system and method

described herein is botulinum toxin or botox ; though it will

be appreciated that the system and method may be utilized

to deliver any number of other fluids, and therefore , the

present disclosure is not intended to be limited to the use of
any particular fluid (s ). It will be further appreciated that the
system may be used to treat any number of diseases or
conditions in which fluid has to be delivered (e .g ., injected
into ) one or more anatomical structures and /or one or more
locations or regions of an anatomical structure . These dis

eases /conditions may include, but are certainly not limited
to , bladder and urethral dysfunction , overactive bladder
syndrome, benign prostatic hyperplasia , painful bladder
syndrome/ interstitial cystitis , achalasia , and obesity to cite
only a few possibilities . Accordingly , it will be appreciated

that use of the system described herein is not intended to be

limited to the treatment of any particular disease ( s )/ condi

tion ( s ), and /or to the implantation of the devices of the

system at any particular location ( s) within a patient's

anatomy.

[0021 ] With reference to FIG . 1 , there is shown a dia

grammatic representation of a fluid delivery system 10
implanted within the body of a patient, in this case , the body

of a human being. According to an embodiment, the fluid
delivery system 10 (hereinafter “ system 10 " ) generally
includes a port 12 , one ormore catheters 14 , and one ormore

implantable pods 16 . As will be described in greater detail
below , at least one of the catheters 14 ( catheter 14a in FIG .
1 ) is configured to couple ( e. g ., fluidly , electrically, etc .) the
port 12 to at least one of the pods 16 (pod 16a in FIG . 1 ) ,

[0014 ] FIGS. 10a and 10b are diagrammatic and side

while one or more other of the catheters 14 (if applicable )

elevation views of an illustrative embodiment of a pod of the
fluid delivery system illustrated in FIG . 1 , with the needle

are configured to couple two adjacent pods 16 together and

assembly thereof in a retracted state and a deployed state,

respectively ;
[0015 ] FIGS. lla and 11b are diagrammatic and side
elevation views of another illustrative embodiment of a pod

to facilitate fluid communication and , in at least some
embodiments, electrical connection /communication , ther
ebetween (e. g ., catheter 14b couples pod 16a to pod 16b , and
catheter 14c couples pod 16b to pod 160 ). In at least some
embodiments , the system 10 may include additional com
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ponents, for example and without limitation , an interrogator

(0025 ] The port 12 may include one or more fluid pas

18 or other base station configured to communicate with

sageways 40 in fluid communication with the reservoir to
allow fluid to flow out of the reservoir 32 . The passageway
(s ) 40 may extend from the bottom of the reservoir 32 (e . g.,
from a bottom wall of the reservoir 32 (as shown in FIG . 3 ))
or from a sidewall (as shown in , for example , FIGS. 6 and

electronics housed within the port 12 and /or pod (s) 16 . In

other embodiments, however, that or those additional com
ponents may be separate and distinct from the system 10 but

may be used in conjunction therewith .

[0022] In an embodiment, the port 12 may be an implant
able port configured to be implanted underneath the surface
of the skin and to be held in place by, for example, suturing
the port 12 to a muscle wall or another anatomical structure

beneath the surface of the skin . As illustrated in , for

example , FIGS. 2 and 4 , the port 12 generally comprises a

body 20 that, in an embodiment, includes a first portion 22
and a second portion 24 , and includes or defines a central

axis A . The first and second portions 22 , 24 may be
integrally formed so as to form a single piece , or, alterna
tively , may comprise separate pieces that are operatively
coupled together (i.e., directly coupled or indirectly coupled
via intervening component(s) using techniques well-known
in the art (e.g., friction or interference fit connections ,
threaded connections , mechanical fasteners , and/ or adhe
sives , to cite just a few possibilities ).
[ 0023] In an embodiment, the first portion 22 of the port
12 has a first end 26 and a second end 28 opposite the first

7 ), though other configurations and arrangements are cer

tainly possible . In an embodiment such as that illustrated in

FIGS. 2 and 3 , the passageways (s ) 40 fluidly couple the

reservoir 32 to the catheter 14 that , in turn , couples the port

12 with one or more of the pods 16 .
100261 In other embodiments such as, for example , that

illustrated in FIGS. 4 -7 , the passageway ( s) 40 fluidly couple
the reservoir 32 to one or more chambers 42 ( e . g ., a plurality
of chambers) disposed in the first portion 22 of the port 12 .
In such an embodiment, fluid flows from the reservoir 32 to

the chamber 42 before flowing to the catheter 14 . By way of

illustration , the first portion 22 of the port 12 may include a
FIGS. 4 -7 , four (4 ) chambers 42 (i.e., chambers 42a , 426 ,

plurality of chambers 42 , for example and as illustrated in

42c, and 42d ), each corresponding to one or more pods 16
of the system 10 . It will be appreciated that while the
illustrated embodiment includes four (4 ) chambers , in other
embodiments , the port 12 may include more or fewer than

four (4 ) chambers. Accordingly , the present disclosure is not

end 26 . The first portion 22 further includes an opening 30
at a first end 26 providing access to a fluid reservoir 32

limited to the port 12 including any particular number of

disposed within the first portion 22 . In an embodiment , the

ment illustrated in FIGS. 4 - 7 includes four (4 ) chambers, the
port 12 includes four (4 ) passageways 40 (40a , 406 , 40c , and
40d shown in FIG . 7 , for example ), each of which is

port 12 includes a diaphragm or septum 34 that is carried by
the body 20 ( e . g ., the first portion 22 of the body 20 ) and that
extends across and overlays the opening 30 . The septum 34
is penetrable by a needle of or carried by a syringe to fill the
reservoir 32 with fluid that is to be delivered to the pod ( s ) 16 .
In an embodiment, the septum 34 may comprise a silicon

membrane; though in other embodiments the septum 34 may
take other forms. The septum 34 may be coupled to the first
port 22 in a number ofways. One way comprises affixing the
septum 34 to an affixation surface ( not shown ), which may
be an axially - facing surface that faces away from the body

chambers . In any event, because the port 12 in the embodi

configured to allow fluid in the reservoir 32 to flow into a
respective chamber 42 . In an embodiment, the fluid pas

sageways 40 either comprise or have disposed therein ,
one -way valves to allow fluid to flow from the reservoir 32
to the chambers 42, but to prevent the flow of fluid in the
opposite direction . In such an embodiment, any suitable

one -way valve may be used , as the present disclosure is not

intended to be limited to any particular type(s ).
[0027] Each chamber 42 may be defined or bounded by

20 of the port 12 , using a suitable adhesive . In another
embodiment, the septum 34 may be coupled to the port as

one ormore interior walls of the first portion 22, and may be

port 12 . In such embodiment, both the periphery of the

fluid to flow out from the chamber 42 . Accordingly, in an
embodiment such as that illustrated in FIGS . 6 and 7
wherein the port 12 includes four (4 ) chambers 42 (i.e.,

part of the molding process used to form or construct the
septum 24 and the affixation surface may be encapsulated in

the port 12 during the port manufacturing process. It will be
niques may additionally or alternatively be utilized .
[0024 ] In an embodiment, the reservoir 32 extends from
the opening 30 at the first end 26 of the first portion 22 to an
intermediate pointbetween the first and second ends 26 , 28
of the first portion 22 , and may be defined or bounded by one
appreciated , however, that other suitable coupling tech

or more walls . For example , in the embodiment illustrated in
FIGS. 2 and 3 , the reservoir 32 may include one or more side
walls 36 extending axially from the opening 30 (or in close
proximity thereto ) to a bottom wall 38 . In another embodi
ment, such as , for example , that illustrated in FIG . 4 , the
reservoir 32 may have a substantially funnel or conical
shape having one or more side walls 36 extending both

axially and radially - inward from the opening 30 to a point or

coupled with one or more drains 44 in the port 12 to allow

chambers 42a -42d ), there may be four ( 4 ) drains 44 (i. e .,

drains 44a -44d ) . Each drain 44 may extend from the corre
sponding chamber 42 to a connector member or element 46
carried in or by the first portion 22 of the port 12 that is
configured to mate with the end of the catheter 14 (e . g ., a

complementary connector member at the end of the catheter
14 ), and that allows fluid to flow from the port 12 to the

catheter 14 . The drain (s ) 44 may be arranged in such a
manner that when the catheter 14 is coupled or connected to

the port 12, each drain 44 is aligned with a corresponding

lumen of or in the catheter 14 . The connector member 46

may comprise a male or female connector member, and may
comprise any suitable connector known in the art that will
facilitate the passage of fluid from the port 12 to the catheter

14 . As such , the present disclosure is not limited to any

bottom wall located between the first and second ends 26 , 28

particular type (s ) of connector members or connection tech

of the first portion 22 . Accordingly , it will be appreciated

niques .

that the reservoir 32 is not limited to any particular con

[0028] With reference to FIGS. 5 and 8 , the second portion
24 of the port body 20 is configured to house various

figuration (s), but rather any suitable configuration may be

utilized .

electronics used in the control and operation of the system
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10 . In an embodiment, the port 12 also includes an electro

ponents (e . g ., base station ) located , for example , at a
patient 's bedside . In at least certain embodiments, the trans

portion 24 and that is comprised of one or more electrical

mitter / receiver 56 may be additionally or alternatively con

contacts 50 to allow the port 12 , and the electronics stored

figured to receive , for example , readings from wireless
sensors (e . g ., flow sensors ) located in the pod ( s ) 14 of the
system 10 . In any event, in an embodiment, the transmitter /

mechanical connector 48 that is carried by the second

therein , in particular, to be electrically connected to the
pod( s ) 16 . Any number of electrical components may be
housed within the second portion 24 , including, but not
limited to , one or more of an electronic control unit (ECU )
52, a power source 54 , a transmitter/receiver ( e . g ., a trans
ceiver ) 56 , an ohm meter 58 , one or more switches or switch
ar
arrays , and various conductors or wires to allow each the

components to be connected to each other and /or to the

electrical contacts 50 of the electromechanical port 48 .

[0029 ] The ECU 52 may include any variety of electronic

processing devices , memory devices, input/output (I/O )
devices , and / or other known components, and may perform
various functions relating to , for example , the operation and

receiver 56 is electrically connected to the ECU 52 so as to

allow for data and other information to be passed to and

from the ECU 52 . Again , it will be appreciated that any
suitable type of transmitter/receiver may be used , as the
present disclosure is not limited to any particular type of
transmitter/receiver.
[0032 ] As is well- known in the art, the ohmmeter 58 is
configured and operable to measure electrical resistance or
impedance . As will be described in greater detail below , the
ohmmeter 58 is configured to measure the electrical resis
tance or impedance between two or more of the pods 16 ,

control of the system 10 . In an illustrative embodiment, the
ECU 52 comprises an electronic memory device and an

which , in an embodiment, comprises the resistance or
impedance of tissue proximate two or more of the pods 16 .

electronic processing device . The electronic memory device
is configured to store various information , instructions ,
software, algorithms, data , threshold values, etc . to be used

includes an ohmmeter that is separate and distinct from the

in the control and operation of the system 10 . The electronic

While in an embodiment the port 12 , and thus the system 10 ,

ECU 52, in other embodiments , the functionality of the
ohmmeter 58 may be integrated within the functionality of

processing device , which may comprise , for example , and
without limitation , a microprocessor , a microcontroller, an
application specific integrated circuit (ASIC ), etc ., is con
figured to execute instructions for software , firmware , pro

the ECU 52, and thus, the ECU 52 comprises the ohmmeter

grams, algorithms, scripts , etc . that are stored in thememory

[0033 ] As briefly described above , in addition to the
components described above, one or more switches 60 or

device of the ECU 52 , and may at least partially govern
some or all of the processes and methods described herein .

[0030 ] The power source 54 may comprise one or more
batteries or any other suitable power source known in the art ,
and may serve a number of purposes . For instance , it may

provide operating power to other components housed within
the second portion 24 of the port 12 , and /or to components

or devices located in the pod ( s ) 16 of the system 10 . The

power source 54 may also be used to facilitate impedance
measurements of tissue proximate one or more of the pod (s )
16 . Accordingly, the power source 54 may take any number
of forms and may serve any number of purposes , including
purposes not expressly described herein .
[0031 ] The transmitter /receiver 56 may comprise a com
bined transmitter/receiver (i.e., a transceiver), or may com
prise a transmitter and a separate receiver. In either instance ,
the structure and function of the transmitter/receiver 56 is

well known in the art, and as such , a detailed description will

not be provided . To summarize, however, the transmitter/
receiver 56 may comprise any suitable transmitter/receiver
known in the art capable of receiving and transmitting
electrical signals, for example, radio frequency (RF ) signals .
To that end , the transmitter/receiver 56 may include an

antenna and other components required for receiving and

transmitting electrical signals in the manner required for

operating the system 10 . The transmitter/receiver 56 may be
configured to facilitate wireless communications between

58 . Accordingly, it will be appreciated that any number of
configurations or arrangements of the ohmmeter 58 may be

utilized
* 124 ..

arrays of switches 60 may also be housed in the second

portion 24 of the port 12 . As will be described in greater
detail below , some or all of these switches 60 may be used
to electrically connect certain electronics or electrical com
ponents in the port 12 with one or more components in the
pods 16 . For example , a switch 60 may be configured to

electrically connect the power source 54 to a fluid control
valve located in a pod 16 . Another switch 60 may be
configured to electrical connect the power source 54 to a
needle actuation mechanism (e. g., electromagnet (s), piezo
electric element(s ), etc.) located in a pod 16 . Switches may
also be used to electrically connect electrodes (e . g ., needles )
in the pods 16 to, for example, the ohmmeter 58 or ECU 52,
and /or sensors ( e .g ., flow sensors ) in the pods 16 to the ECU
52. In any event, operation of the switches 60 may be
controlled by the ECU 52 such that the ECU 52 may
command the opening and closing of the switches. Addi
tionally, the switches 60 may comprise any suitable type of
switch , for example , solid state switches and/or electrome
chanical switches, the operation of which is/ are well known

in the art. Accordingly , it will be appreciated that any

number of switches 60 may be provided to selectively

connect various components of the port 12 and pods 16

together, and that different types of suitable switches may be

used .

[0034 ] The electromechanical port 48 in or carried by the

the port 12 (and the ECU 52 thereof, in particular ) and one

body 20 of the port 12 may comprise any suitable electro

or more other components of the system 10 , and /or between
the port 12 and one or more other components or devices

mechanical connector known in the art, and is configured to
be mated with a complementary electromechanical connec

that are not part of the system 10 , but that are nonetheless

tor of the catheter 14 . As shown in FIG . 8 , the electrome
chanical connector 48 may comprise a female connector

used in conjunction with the system 10 . For example , the
transmitter/receiver 56 may be configured to receive instruc
tions, commands, and/ or information from , and/or to send

instructions , commands, and/ or information to , an interro

gator ( the interrogator 18 described below ) or another com

such that it is adapted to receive a complementary male
connector of the catheter 14 , or may comprise a male
connector configured to be inserted or plugged into a female

connector of the catheter 14 . Accordingly, the present dis
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closure is not limited to the use of any particular type of

electromechanical connector, but rather any suitable con nector may be used .

[0035 ] As briefly described above , the system 10 includes

one or more catheters 14 . In an embodiment wherein the
system 10 includes a single pod 16 , the system 10 may

include a single catheter 14 for coupling the port 12 with the

to couple or connect ( e.g ., fluidly, electrically, etc .) the

catheter 14 between or to the port 12 and a pod 16 , or
between or to a pair of pods 16 to facilitate fluid and /or

electrical communication /connections between the compo
nents being coupled together.More particularly , each end of
a given catheter 14 may include or carry a connector (not
shown ) that is configured to be mated with a complementary

pod 16 and for facilitating fluid communication and /or

connector of either the port 12 or a pod 16 so as to allow

electrical connection ( s ) therebetween . However, in an
embodiment wherein the system 10 includes a plurality of

or from the catheter 14 to a pod 16 , as the case may be. Each

pods, a plurality of catheters 14 may be provided . For

example , in the embodiment illustrated in FIG . 1 wherein

the system 10 includes three (3 ) pods 16a - 16c, the system

includes three ( 3 ) catheters 14 - catheter 14a coupling the port

12 to the first pod 16a , catheter 14b coupling the first pod

16a to the second pod 16b , and catheter 14c coupling the
second pod 16b to the third pod 160. Accordingly, the

number of catheters 14 included in the system 10 may be
dependent, at least in part , on the number of pods 16

included in the system 10 .
[0036 ] With reference to FIG . 9 , each catheter 14 has a

shaft 62 having a first end and a second end opposite the first

end , and that in an embodiment comprises a flexible shaft.
The shaft 62 further includes one or more fluid lumens 64
disposed therein extending between the first and second

ends. As shown in FIG . 9 , the fluid lumens 64 may be
integrally formed into the catheter shaft 62 , or alternatively

may comprise one or tube( s ) that are bundled within with the
shaft 62 . In either instance , the number of fluid lumens 64
that the catheter 14 includes may be dependent, at least in
part, on the number of pods 16 in the system 10 , and /or the
number of pods 16 downstream from that particular catheter

14 . For example , in an embodiment such as that illustrated
in FIG . 1 wherein the system 10 includes three ( 3 ) pods 16 ,
the shaft 62 of at least the catheter 14a that couples the port

12 to the first pod 16a may include three ( 3 ) lumens 64 , each
one feeding a respective one of pods 16a - 16c . In another
embodiment, however, the shaft 62 may include a single
fluid lumen 64 that feeds all three pods 16a - 16c . In such an
embodiment, the catheter 14 may include orifices or outlets
to which the pods 16a - 160 may be coupled and through

which fluid flowing through the single lumen 64 may pass to
the pods 16a - 16c . In other words, the catheter 14 may have
a number of branches, each one of which is configured to be
coupled to a respective pod 16 to supply fluid thereto .
Accordingly, it will be appreciated that the number of
lumens 64 that a shaft 62 of a given catheter 14 may have
is not limited to any particular number, but rather different

catheters 14 may have different numbers of lumens 64 .
[0037 ] In addition to the fluid lumen (s ) 64 , the shaft 62 of

a catheter 14 may further include one ormore passageways
66 for housing electrical wires or conductors that extend

from the first end of the catheter shaft 62 to the second end,
and which may be used for electrically connecting electron
ics or electrical components in the port 12 to various
components in the pods 16 ( e . g ., valves , sensors, needle

actuators , etc . ). In other embodiments, the conductors /wires
may be routed through the catheter ( s ) 14 in a manner other
than through a passageway 66 , or even possibly through the
fluid lumen (s ) 64 .

[0038 ] In any event, the fluid lumens 64 and electrical
conductors extending through the shaft 62 of a catheter 14
may each terminate at one or more connectors disposed at
either end of the shaft 62 . These connectors are configured

fluid to flow from the port 12 or pod 16 to the catheter 14 ,
end of the given catheter 14 may further include or carry an
electromechanical connector 68 configured to be mated with

a complementary electromechanical connector of either the
port 12 (e . g ., electromechanical connector 48 ) or a pod 16 to
electrically connect the electronics or electrical components
of the port 12 to the electrical conductors in the catheter 14 ,

or the electrical conductors in the catheter 14 to electrical
conductors or components in the pod 16 to which the
catheter 14 is being coupled . As shown in FIG . 9 , the
electromechanical connector 68 on at least one end of one
catheter 14 may comprise a male connector that includes a

plurality of electrical contacts 70 ; though it will be appre
ciated that a female connector configured to receive a
complementary male connector may certainly be used

instead . In any event, the connectors of the catheter 14 may

comprise any suitable connectors known in the art, includ

ing, for example, a single connector that facilitates both the
electrical connection and fluid communication between the

components the catheter 14 is coupling together, as opposed

to two separate connectors on one end of the catheter 14 . As
such , the present disclosure is not limited to any particular

type( s) of connectors or connection techniques for the
catheters 14 .

[0039] As will be appreciated in view of the foregoing, the

system 10 may include one pod 16 or a plurality of pods 16

that may be linked or chained together ( see , for example ,

FIGS . 1 and 14 ). In either instance, each pod 16 is config

ured to be implanted in the body of a patient at a particular

location at which the delivery of a particular fluid is needed
or desired (i.e ., at a desired injection site ). In an embodi
ment, the pod 16 may be held in place by suturing the pod
16 to the organ or another anatomical structure to which

fluid is being provided . As illustrated in , for example , FIGS.

10a - 13 , each pod 16 comprises a housing 72 having a first
end 74 and a second end 76 , and includes or defines an axis

B . The housing 72 further includes a base 78 that, for reasons

that will become apparent below , includes an axially extend

ing aperture 80 disposed therein . It will be appreciated that

unless otherwise noted , the description below of a pod 16

applies with equal weight to each pod 16 of the system 10 .
[0040 ] As best shown in FIG . 13 , the housing 72 of the

pod 16 is configured to house various components of the pod

16 , including, for example and without limitation , a deploy
able needle assembly 82 , one or more fluid flow control
valves 84 , one or more sensors 86 , and/ or various electrical
conductors (e . g ., wires ) and /or fluid passageways , to cite a
few possibilities. The housing 72 is also configured to carry

one or more connectors of the pod 16 ( e. g ., one or more of
the mechanical or electromechanical connectors described
elsewhere above ) for coupling or connecting ( e. g ., fluidly ,

electrically , etc .) the pod 16 to one or more catheters 14 to
facilitate fluid and/or electrical communications or connec

tions between the pod 16 and the port 12 , and /or between the

pod 16 and one or more other pods 16 of the system 10 . In
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other words, the connector (s) carried by the housing 72 of a

given pod 16 may be mated with complementary connector

( s ) of one or more catheters 14 in order to fluidly and /or
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needle 90 to move between the retracted and deployed
states. In any event, fluid from one or more fluid lumens 64

in the catheter 14 may flow through the connector to the

electrically connect or couple the pod 16 to the port 12
and / or one or more other pods 16 . For example , in the

passageway( s ) 95 in the pod 16 , and from the passageway ( s )
95 to the channel 94 in the needle 90 . As will be described

illustrative embodiments shown in FIGS . 10a - 13, each pod

below , a valve 84 may be used to control when fluid in the
passageway (s ) in the pods is ultimately allowed to flow to
and / or through the channel 94 in the needle 90 , and thus, into

16 includes a pair of electromechanical connectors 88 that,

in this particular embodiment , comprise female connec

torsone (connector 88a ) configured to be mated with a

complementary electromechanical connector 68 of a first

catheter 14 , and the other connector 88b ) configured to be

mated with a complementary electromechanical connector
68 of a second catheter 14 . In any event, and as with the
connectors of the catheter (s ) 14 and port 12 described above ,
the connector ( s ) of the pod (s ) 16 may comprise any suitable
connectors known in the art as the present disclosure is not

intended to be limited to any particular type (s ) of connectors

or connection techniques for the pod (s ) 16 .
[0041] Turning now to the components housed within the

housing 72 , the needle assembly 82 generally comprises a
needle 90 and an actuation mechanism 92 to move the
needle 90 between retracted and deployed states . In at least

some implementations, the needle assembly 82 may further

include a guide or track 93 (best shown in the illustrative

embodiment depicted in FIGS. 12a and 12b ) to which the
needle 90 may be secured /mounted to and supported by, and

along which the needle 90 may travel when moving between
the retracted and deployed states . In at least some embodi

ments, when the needle assembly is in the retracted state, the
entire needle assembly 82 is disposed within the housing 72

of the pod 16 . Conversely , when in the deployed state , at
least a portion of the needle 90 extends through the aperture

80 in the housing 72 so as to engage and puncture the
anatomical structure to which fluid is being delivered ,
thereby allowing fluid to be delivered to that structure .

Accordingly , in an embodiment the needle 90 is arranged so
as to be axially - aligned with the aperture 80 in the housing
72 to allow the needled to extend through the aperture 80

and into the anatomical structure .
[0042 ] The needle 90 may serve a number of purposes . For
one, it may provide a pathway for fluid to pass from the pod
16 and into the anatomical structure to which fluid is being
delivered . Accordingly, the needle 90 may be a hollow
needle having a channel 94 therein through which fluid
supplied to the needle 90 may pass . More particularly, and
as will be described more fully below , the pod 12 may
include one or more fluid passageways (e .g ., tube(s )) 95 that
fluidly couple the needle 90 to a connector in the housing 72
that, in turn , is coupled to a catheter 14 . The needle 90 may
be coupled to a passageway ( e . g ., passageway 95a ) in a
number of ways . For example , the end of the passageway
95a may be sized and shaped to receive a portion of the
needle 90 , which may be inserted into the passageway and
held snuggly in place . In other embodiments, a collar
overlying both a portion of the passageway 95a and a
portion of the needle 90 may be used to couple and hold the
passageway 95a and needle 90 together. Accordingly, it will
be appreciated that any number of techniques may be used
to couple the passageway and needle together, as the present

the anatomical structure .
[0043] The needle 90 of a given pod 16 may also serve a

sensing function or purpose . As will be described in greater
detail below , the needle 90 may act as a sensing electrode to

measure or sense one or more electrical, electrophysiologi
cal, or chemical parameters of interest, or parameter( s ) that

may be used to derive one or more parameter(s) of interest.
For example , in an embodiment, the needle 90 may be used
to measure or sense the electrical resistance or impedance in
an area or region between two or more pods 16 ( e .g ., the
impedance of a region of the anatomical structure to which

fluid is being delivered ), to cite just one example. To that

end , at least a portion ( i. e ., the tip of the needle 90 may be
electrically conductive , and may have one or more electrical
conductors attached or affixed thereto extending from the
needle 90 to an electromechanical connector 88 of the pod
16 . When a catheter 14 is electrically connected between

that pod 16 and the port 12 via that connector 88 , the needle
ponents in the port 12 and one or more parameter(s ) of
interest may therefore be measured or sensed .

90 is electrically connected to one or more electrical com

[0044 ] The actuation mechanism 92 of the needle assem

bly 82 is operable to cause the needle 90 to move between
the retracted and deployed states and , in at least some
embodiments , to control the flow of fluid through the needle
90 . The actuation mechanism 92 may include a number of

components and may be implemented in a number of ways.

10045 ] One illustrative way is that illustrated in FIGS . 10a
and 10b and involves the use of magnetic fields or forces to

actuate the needle assembly 82 . More particularly , the
actuation mechanism 92 includes one or more electromag

nets (e .g., solenoids) 96 disposed at or near the base 78 of
the housing 72 . As is well known in the art, each electro

magnet 96 may include a coil 97 formed of an electrical

conductor ( e. g ., wire ) wound around a magnetic core or
armature 98 that is movable relative to the coil. The needle

90 is coupled to the armature (s ) 98 of the electromagnet(s )
96 such that the needle 90 moves as the armature ( s ) 98

move. The electromagnet(s ) 96 , and the coil (s ) 97 thereof, in
particular, may be electrically connected to a power supply,
for example , the power supply 54 in the port 12 , via one or

more switches and electrical conductors in the port 12 , the

pod 16 (e. g., conductor(s ) 99 , and the catheter(s ) 14 con
necting (directly or indirectly ) the port 12 with the pod 16 .
When the electromagnet ( s ) 96 is /are energized (i.e ., current
is applied ), a magnetic field is generated that causes the
armature ( s) 98 , and therefore , the needle 90 coupled thereto ,
to be pulled in an axially - downward direction from the
retracted state ( FIG . 10a ) to the deployed state (FIG . 106 ) .

The actuation mechanism 92 further includes one or more

springs 100 to bias the needle 90 and to cause it to retract

disclosure is not intended to be limited to any particular

once the electromagnet(s ) 96 is/ are de -energized . In the

passageway (s) 95 (e.g., passageway 95b in FIGS. 10a - 12b )

circumscribes the needle 90 ; though other suitable spring
arrangements may certainly be used instead . In an embodi

technique( s ). In embodiment, one or more of the fluid

may be sufficiently flexible and/ or extendable or expandable
in an axial direction towards the needle 90 so as to allow the

embodiment illustrated in FIGS . 10a and 10b , the spring 100

ment, the electromagnet(s) 96 may be selectively energized
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using one or more of switches disposed between the coils
and the power source 54 in the port 12 . The switch or
switches may be disposed within the port 12 (e .g ., one or
more of the switches 60 in the port 12 ) and/or the housing
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[0047 ] Yet another way in which the actuation mechanism
92 may be implemented is that illustrated in FIGS . 12a and
12b and involves the use of pressure to actuate the needle

assembly 82 , and thus may be considered to be a hydraulic

72 of the pod 16 , and may be controlled by the ECU 52
disposed in the port 12 . Accordingly, when it is determined
that an injection of fluid is needed at the location of the

actuation mechanism . More particularly , as fluid is supplied

the ECU 52 causes the switch or switches corresponding to

state ( FIG . 12a ) to the deployed state (FIG . 12b ) along the
track 93 , which , in this embodiment, may comprise one or

anatomical structure that corresponds to a particular pod 16 ,

that pod 16 to close , thereby causing the electromagnet(s ) 96
to be energized and a magnetic field having a magnitude
sufficient to overcome the bias of the spring 98 to be

generated . As the needle 90 is pulled in an axially - downward
direction toward the base of the housing 72 (i.e ., towards the
anatomical structure ), the spring 100 compresses . When it is
subsequently determined that the needle 90 is to be retracted ,
the ECU 52 may cause the appropriate switch ( es ) to open ,

thereby de -energizing the electromagnet(s ) 96 . The de
energizing of the electromagnet (s) 96 results in the removal
of or reduction in the magnetic field such that the spring 100
expands thereby causing the needle 90 to retract back to the
retracted state .

to the pod 16 and flows to the channel 94 of the needle 90 ,
the pressure of the fluid may cause the needle 90 to be

pushed in an axially -downward direction from the retracted
more hydraulic rams. The pressure that causes the needle

assembly 82 to actuate may be that of the fluid itself ( e. g.,
when a certain amount of fluid has flowed to the needle 90 ,
the pressure applied to the needle assembly by the fluid

causes the needle 90 to move downwardly ), may be the
pressure applied to the fluid by a physician / clinician who is

infusing the port 12 with the fluid (e. g ., the pressure applied
via the plunger of a syringe used to infuse the port 12 ), or

a combination of both . Once the needle 90 has been

deployed and the desired amount of fluid has been injected
into the anatomical structure , the pressure lessens and the

may be implemented is that illustrated in FIGS. 11a and 11b

and involves the use of piezoelectric elements to actuate the

needle 90 moves back to the retracted state . In an embodi
ment, the hydraulic ramsmay include one or more springs
or other resilient elements to facilitate the movement of the
needle 90 back to the retracted state , much like the spring
100 in the embodiment illustrated in FIGS. 10a and 10b . In

needle assembly 82 . More particularly , the actuation mecha

mechanism 92 comprises the needle 90 and the track 93 of

[0046 ] Another way in which the actuation mechanism 92

nism 92 includes one or more piezoelectric elements 102

carried within the housing 72 of the pod 16 that may be
selectively electrically connected to , for example , the power
supply 54 in the port 12 via one or more switches and
electrical conductors in the port 12 , the pod 16 (e .g .,
conductor (s ) 103 ), and the catheter(s ) 14 connecting ( di
rectly or indirectly ) the port 12 with the pod 16 . As is known
in the art, when electric current is supplied to the piezoelec
tric element( s ) 102, the element(s ) 102 deform ( s ). This

deformation causes the needle 90 coupled to the piezoelec
tric element( s ) 102 to be pushed in an axially - downward
direction from the retracted state (FIG . 11a ) to the deployed
state (FIG . 11b ). When the current is subsequently removed ,
the piezoelectric element(s ) 102 revert back to their original

any event, in the illustrative implementation , the actuation

the needle assembly 82 .
[0048 ] While certain particular ways in which the needle
actuation mechanism 92 may be implemented have been

described above, it will be appreciated that any suitable

implementation may be used as the needle actuation mecha
nism 92 is not limited to any particular implementation(s ).
[0049] As mentioned above and shown in FIGS . 10a - 14 ,
in at least some embodiments the pod 16 includes one or

more valves 84 and / or one or more sensors 86 . The valve( s )
84 and / or sensor ( s ) 86 are housed within the housing 72 and

may be used in the control and /or monitoring of fluid
flowing through the pod 16 . The valve ( s ) 84 and/ or sensor ( s )

state and the needle 90 moves back to the retracted state . In

may comprise constituent components , for example , the
needle assembly 82 (and the actuation mechanism 92

piezoelectric element( s ) 102 using one or more of switches

other components of the pod 16 . In either instance , the

an embodiment, current may be selectively applied to the

disposed between the piezoelectric element(s ) 102 and the
power source 54 in the port 12 . The switch or switches may

be disposed within the port 12 (e . g ., one or more of the
switches 60 in the port 12 ) and/ or the housing 72 of the pod

16 , and may be controlled by the ECU 52 disposed in the

port 12 . Accordingly , when it is determined that an injection
of fluid is needed at the location of the anatomical structure

that corresponds to a particular pod 16 , the ECU 52 causes
the switch or switches corresponding to that pod 16 to close ,
thereby causing current to be applied to the piezoelectric
element(s ) 102 . As the piezoelectric element(s ) 102 deform ,
the needle 90 is pushed in an axially -downward direction
toward base of the house 72 ( i.e ., towards the anatomical
structure ). When it is subsequently determined that the
needle 90 is to be retracted , the ECU 52 may cause the
appropriate switch (es ) to open to remove the current from
the piezoelectric element( s ) 102 , thereby causing the piezo
electric element (s ) 102 to revert back to it/ their original state

and causing the needle 90 to retract back to the retracted
state .

thereof, in particular) or may be separate and distinct from

valve (s ) 84 and/ or sensor (s ) 86 may be necessary in embodi
ments wherein the needle 90 may be deployed without

delivering fluid to the anatomical structure. For example, in
an embodiment wherein the needle 90 serves a sensing
function , it may be desirable for the needle to be deployed
and to puncture the anatomical structure , but it may not be
desirable for the needle 90 to also deliver fluid to the
structure while the sensing function is being performed .
Such components may also be necessary in embodiments
wherein a particular amount of fluid (dosage) is being

delivered to the anatomical structure . For example , itmay be
desirable to stop the delivery of fluid once a particular

amount has been delivered .
[0050 ] To that end, and with reference to FIG . 13, for
example , a valve 84 may be disposed anywhere in the fluid
path between the catheter 14 that supplies fluid to the pod 16
and the needle 90 . In an embodiment, such as, for example ,
that illustrated in FIG . 13 ( and those illustrated FIGS.
10a - 12b ), the valve 84 may be coupled between two fluid

passageways 95 (i.e ., 95a and 95b ) in the pod 16 and
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configured to selectively allow fluid to flow therebetween .
The valve 84 may be an electrically controlled valve that
may be selectively coupled to , for example , the power
source 54 of the port 12 by one or more switches (e .g ., one

appreciated that the pod 16 may include one or more flow

port 12. Accordingly, in an embodiment, the valve 84 may

electrical conductors already described above, in certain

one or more electrical conductors of one or more catheter ( s )

include any number of additional fluid pathways and /or

or more switches 60 disposed in the port 12 ), which , in turn ,
may be selectively controlled by the ECU 52 housed in the
be coupled to electrical components in the port 12 through

sensors 86 to monitor the flow of fluid through different
areas of the pod 16 , and that the sensor (s ) 86 may comprise
any suitable flow sensor known in the art that is configured

to measure or sense the fluid flow .
[0052 ] In addition to the fluid passageways/pathways and
embodiments or implementations , a given pod 16 may

14 that connect, directly or indirectly, the port 12 to the pod
16 , and one or more electrical conductors 104 in the pod 16
that electrically connect the valve 84 to the conductor (s) of

wherein the system 10 includes two or more pods 16 , one or

the one or more catheters 14 ( e . g ., electrical conductor( s )

106 and/ or one or more electrical conductors 108 extending
therethrough to allow downstream pod ( s ) 16 to be opera

extending from the valve 84 to an electromechanical con

nector 88 of the pod 16 that is configured to be electrically
connected to electrical conductor( s ) of a catheter 14 that, in

electrical conductors . More particularly, in an instance
more of the pods 16 may include one ormore fluid pathways

tively coupled or connected to the port 12 so as to facilitate
fluid communication and / or electrical connections between

turn , is connected to the port 12 ). The valve 84 may
comprise any suitable valve known in the art that is config
ured for use in controlling the flow of fluid as the present
disclosure is not intended to be limited to any particular type

the downstream pod ( s ) 16 and the port 12 . In such an

10051]. Like the valve 84 , the flow sensor 86 may also be

nected to respective catheters 14 , thereby bypassing any of
the other components of the pod 16 described above (e . g .,

of valve.

disposed anywhere in the fluid path between the catheter 14
that supplies fluid to the pod 16 and the needle 90 , and may
preferably be disposed between the valve 84 in the pod 16
and the needle 90 . Readings from the sensor 86 may be
communicated back to the electronics in the port 12 ( e.g.,
ECU 52) and used for a variety of purposes , including, but
not limited to , those described herein . Depending on the
implementation , the readings may be communicated wire
lessly or over one or more electrical conductors. In the latter
instance , the sensor 86 may be coupled to the appropriate
electronics in the port 12 through , for example , one or more

electrical conductors of one or more catheter(s ) 14 that

connect, directly or indirectly , the port 12 to the pod 16 , and

one or more electrical conductors 105 in the pod 16 that
electrically connect the sensor 86 to the conductor( s ) of the
one or more catheters 14 (e . g ., one or more electrical
conductors extending from the sensor 86 to an electrome
chanical connector 88 of the pod that is configured to be
connected to electrical conductors of a catheter 14 that , in
turn , is connected to the port 12 ) . Readings from the sensors

may be used to determine that fluid is , in fact, flowing to the

pod and /or through the needle 90 thereof, and/or to deter
mine how much fluid has flowed therethrough . As will be
described below , these readings may then be used in the
control the valve (s ) 84 in the pod 16 . For example , the ECU

52 in the port 12 may be configured to use readings from the

sensor 86 to monitor the amount of fluid that has been

delivered to the anatomical structure by that pod 16 . When
the sensed amount of fluid reaches a predetermined thresh

old programmed into the memory of the ECU 52, the ECU
52 may cause the valve (s ) 84 of that pod 16 to close , thereby

preventing the further delivery of fluid to the anatomical
structure . In another embodiment, readings from the sensor

86 may be used to determine when to deploy the needle 90 .
More particularly , upon the receipt of readings from the flow

sensor 86 indicative of fluid reaching the pod 12 /needle 90 ,

embodiment, these " additional” fluid pathway (s) 106 and /or
( e.g ., mechanical and /or electromechanical connectors ) in
electrical conductors 108 may extend between connectors

the housing 72 that are configured to be coupled or con

the needle assembly 82 ).

10053 ] To better illustrate, FIG . 14 illustrates an embodi
pods 16 (i. e., 16a- 16d). In this embodiment, the pod 16a
(which is also illustrated in FIG . 13 ) is connected or coupled

ment of the system 10 wherein the system includes four (4 )
to the port 12 via the catheter 14a and to the pod 16b via the
catheter 14b . The pod 16a includes the fluid pathway 95 that
allows fluid from a lumen 64 in the catheter 14a to be

communicated to the needle assembly 82 of the pod 16a.
Because there are three ( 3 ) pods downstream of the pod 16a ,
the pod 16a also includes three ( 3 ) additional fluid pathways
106a - 106c , each one corresponding to a respective one of
the downstream pods 166 - 16d . Accordingly, each of the

pathways 106a - 106c extend from the connector of the pod
16a that is mated with the catheter 14a , to the connector of
the pod 16a that is mated with the catheter 14b . The

connector coupling the pod 16a with the catheter 14b is

configured to allow fluid to flow from the pathways 106a

106c in the pod 16a to one or more fluid lumens 64 in the
also include electrical conductors to electrically connect

catheter 14b . In at least some embodiments , the pod 16a may

electrical conductors in the catheter 14a ( and therefore ,
electrical components of the port 12 ) to one or more com

ponents in the pod 16a ( e.g ., the valve 84 , the sensor 86 ,

etc .). The pod 16a would also include electrical conductors
108 to allow each of the downstream pods 16b - 16d to be

electrically connected to the port 12 . Accordingly , the pod
16a may include electrical conductors 108 that extend from

the electromechanical connector 88a of the pod 16a that is

mated with the catheter 14a ( and a connector 68 thereof, in
particular ) to the electromechanical connector 88b of the
pod 16a that is mated with the catheter 14b ( and a connector
68 thereof, in particular ). The connector 88b is configured to
electrically connect the relevant conductors 108 in the pod
16a to electrical conductor ( s ) in the catheter 14b which , as

the ECU 52 may cause the needle 90 to be deployed so that

shown in FIG . 14 , couples pods 16a and 16b together.

the fluid can then be delivered to the anatomical structure .
These are , of course, only a few examples of how readings
from a flow sensor 86 may be used , and it will be appreciated

coupled to the pod 16a via the catheter 14b , and to the pod
160 via the catheter 14c. As with the pod 16a , the pod 16b

that flow sensor readings may be used for any number of
additional or alternate reasons or purposes . It will be further

[0054] As shown in FIG . 14 , the pod 16b is connected or

includes the fluid pathway 95 that allows fluid from a lumen

64 in the catheter 14b ( that passed through the pod 16a ) to
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be communicated to the needle assembly 82 of the pod 16b .

Because there are two ( 2 ) pods downstream of the pod 16b ,
the pod 16b also includes two (2 ) additional fluid pathways
106b and 106c, each one corresponding to a respective one

of the downstream pods 16c and 16d . Accordingly , each of
the pathways 106b , 106c extend from the connector of the

pod 16b that is mated with the catheter 14b , to the connector
of the pod 16b that is mated with the catheter 14c . The

connector coupling the pod 16b with the catheter 14c is
configured to allow fluid to flow from the pathways 106b ,

106c in the pod 16b to one or more fluid lumens 64 in the

catheter 14c . In at least some embodiments, the pod 16b
would also include electrical conductors to electrically con
nect electrical conductors in the catheter 14b ( and indirectly
the electronics in the port 12 ) to one ormore components in
the pod 16b (e . g ., the valve 84 , the sensor 86 , etc . ). The pod
16b would also include electrical conductors 108 to allow
each of the downstream pods 16c and 16d to be electrically

connected to the port 12 . Accordingly , the pod 16b may
include electrical conductors 108 that extend from the

electromechanical connector 88a of the pod 16b that is

mated with the catheter 14b (and a connector 68 thereof, in
particular) to the electromechanical connector 88b of the
pod 16b that is mated with the catheter 140 ( and a connector
68 thereof, in particular ). The connector 88b of the pod 16b
is configured to electrically connect the relevant conductors

in the pod 16b to electrical conductor (s ) in the catheter 14c ,

which , as shown in FIG . 14 , couples pods 16 and 160

together
[ 0055 ] As shown in FIG . 11, pods 16c and 16d would be
arranged or configured in a substantially similar manner as

interrogator 18 to monitor the operation of the pod (s ) in the
system to ensure that all of the pod (s ) 16 are operating in an
expected manner .

[0058 ]. The interrogator 18 may comprise any number of
suitable devices known in the art, and therefore, a detailed
description of the structure and operation of the interrogator
18 will not be provided . To summarize , however, the inter

rogator 18 may include a combination of hardware, soft
ware , and / or other components that enable the communica

tion or exchange of information between a user and the
system 10 , and the electronics in the port 12 thereof, in
particular. For example, the interrogator may include an

electronic processing device (e .g ., a microprocessor, micro
controller, ASIC , etc . ), an electronic memory device , and an
antenna. The interrogator 18 may further include one or
more user interfaces to allow the user to receive information
from and /or provide information to , the system 10 . The

interface (s ) may include, for example, and without limita

tion , a liquid crystal display (LCD ), a touch screen LCD , a

keypad , a keyboard , a microphone, and /or a speaker, to cite
a few possibilities . Again , the present disclosure is not
intended to be limited to any particular type of interrogator

or other like device , but rather any suitable device may be
used .

[0059 ] As at least briefly described above, the system 10
obvious function is the delivery of fluid to one or more
regions or areas of one or more anatomical structures. For
purposes of illustration , one particular way of performing

may be configured to perform one or more functions . One

this function will be described below with respect to the

embodiment of the system illustrated in FIG . 14 ; it will be

that described above with respect to pods 16a and 16b , and

appreciated , however, that other ways may certainly be used
in addition to or in lieu of that described below using

10056 ] In addition to the components described above , in

different embodiments of the system 10 .
[0060] First, the port 12 , catheter (s ) 14 (i.e ., 14a - 14d ), and

therefore, a detailed description of those pods will not be
provided

at least some embodiments or implementations such as that
illustrated in FIG . 1 , the system 10 may further include the
interrogator or base station 18 briefly described above . The
interrogator 18 is configured for wireless communication

with the electronics in the port 12 , and the ECU 52 thereof,
in particular. More specifically , electrical signals may be
passed between the interrogator 18 and the ECU 52 through
the transmitter / receiver 56 housed in the port 12 and elec

trically connected to the ECU 52 . This communication may

be over any number of known communication networks or
links using any number of known communication protocols

( e.g ., personal area networks (PAN ), wireless local area

network (WLAN ) , IEEE 802 . 11 , Wi-Fi, WiMax , etc . ).

[0057 ] The interrogator 18 may be utilized by a user (e.g .,
example , the user may use the interrogator 18 to command
the delivery of fluid by one or more of the pods 16 of the
system 10 . The user may use the interrogator 18 to set or
adjust certain operating parameters of the system 10 (e .g.,

physician or clinician ) for a number of purposes. For

the threshold (s ) corresponding to the maximum amount of

fluid that is to be delivered 16 to a particular location by a

particular pod 16 ). The interrogator 18 may display the
values of one or more parameters (e . g ., electrophysiological

parameter( s )) that are measured or sensed by the electronics

in the port 12 and communicated to the interrogator 18 in

order to allow the user to evaluate the efficacy or of the

treatment being performed via the fluid delivery , and /or to
determine whether adjustments to that treatment are required

(e. g., more fluid is required ). The user may also use the

pods 16 ( 16a - 16d ) are implanted into the body of the patient.

Next, the port 12 is infused with the fluid to be delivered to
the pods 16 and ultimately injected into the anatomical
structure ( s ) to which the pods 16 are affixed . In an embodi
ment, this may comprise locating the septum or diaphragm
34 of the port 12 and inserting the needle of a syringe
through the septum 34 and into the reservoir 32 of the port.

The fluid in the syringe may then be injected into the
As the fluid fills the reservoir , the pressure applied to the
plunger of the syringe causes the fluid to flow equally into
the chambers 42a -42d of the port 12 , through the drains
44a - 44d and into respective fluid lumens 64 in the catheter
14a, and ultimately into the pods 16a - 16d.

reservoir 32 by pushing down on a plunger of the syringe .

[0061] Once the system 10 is loaded with the fluid to be

delivered , one or more needle assemblies 82 in the pods

160- 16d are actuated to deliver the fluid to the anatomical
structure . In an embodiment, this comprises the ECU 52 in
the port 12 determining which of the needle assemblies 82
to actuate , and then causing that or those assemblies to
actuate . This determination may be made automatically by

the ECU 52, or alternatively may bemade in response to a
purposes of illustration only , assume that it is determined
that only the needle assembly 82 of the pod 16a is to be

command or input received from the interrogator 18 . For
actuated . In response to this determination , the ECU 52 may
control one or more switches 60 in the port 12 to couple one

or more components in the pod 16a to the power source 54

in the port 12 to actuate the assembly 82 . Depending on the
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particular implementation , this may comprise , for example ,

controlling one or more switches 60 to cause the needle
assembly 82 to move to the deployed state . This may
additionally or alternatively comprise controlling one or
more switches 60 to electrically connect the valve 84 in the

pod 16a to the power source 54 , thereby opening the valve
54 to allow fluid to flow through the channel 94 in the needle

may be configured to do so in a number ofways. One such

way is that illustrated in FIG . 15 . In this embodiment, the
needle 90 of one of the pods 16 ( e .g ., pod 16a in FIG . 15 )
is electrically connected to the power source 54 in the port
12 to allow current to flow into the anatomical structure

( reference numeral 110 in FIG . 15 ) when the needle 90 is

deployed and penetrates the anatomical structure . The elec

90 .

trical connection between the needle 90 and the power

[0062] In an embodiment, as the fluid flows through the
pod 16a to the needle 90 , readings from the flow sensor 86
may be communicated back to the ECU 52 through con
ductors and or other components (e .g ., switches ) in the pod
16a , catheter 14a , and port 12 . When it is determined by the
ECU 52 that a particular amount of fluid has been delivered
through the needle 90 to the anatomical structure (by, for

source 54 may be through one or more switches 60 in the

port thatmay be controlled by the ECU 52 . The current that

flows into the anatomical structure from the needle 90 of the

pod 16a flows through the needle (s ) 90 of one or more other
pods 16 ( e . g ., pod 16b in FIG . 15 ) when that or those needles
90 are deployed and penetrate (s ) the anatomical structure .
The current then flows back to one or more components in

90 to be retracted . This may comprise , for example , con

the port 12 ( e . g ., the ohmmeter 58 or ECU 52 ) that the
needle ( s ) 90 are electrically connected to where it is used to
measure or calculate the impedance of at least a portion of
the anatomical structure extending between the two needles

trolling the one ormore switches 60 that electrically connect

90 . The electrical connection between the needle 90 of the

example , comparing the readings received from the flow
sensor 86 to a predetermined threshold value ), the ECU 52

may cause the flow of fluid to be stopped and/or the needle

source 54 to disconnect that or those components from the

pod 16b and the electronics of in the port 12 may be
facilitated through one or more switches 60 in the port 12
that may be controlled by the ECU 52 . The current path

move to the retracted state . This may additionally or alter

described above is represented in FIG . 15 by arrows.

that electrically connect the valve 84 in the pod 16a to the
power source 54 to disconnect the valve 84 from the power
source 54 , thereby closing the valve 84 to prevent (or at least
limit ) additional fluid from flowing through the needle 90.

[0067] In embodiment, only the needle 90 of one pod 16
the power source 54 as described above, and only the needle
90 of another pod 16 ( e . g ., pod 16b ) may be selective
electrically connected to the component (s) of the port 12 that

( s ) one or more components in the pod 16a to the power

power source 54 , thereby causing the needle assembly 82 to
natively comprise controlling the one or more switches 60

[0063] In an embodiment, once the desired amountof fluid

has been delivered to the anatomical structure , the system 10
( e. g ., port 12 , catheter ( s ) 14 , and pod ( s ) 16 ) may be flushed

and /or primed with saline or another suitable fluid . This may

( e . g ., pod 16a ) may be selectively electrically connected to

measure / calculate the impedance. In other embodiments ,

however, the needles 90 of multiple pods 16 may be con
figured to be individually selectively electrically connected
to the power source 54 , components of the port 12 for

comprise , for example, infusing the port 12 with saline in the

measuring / calculating impedance , or both . In the latter

above , and then actuating one or more of the needle assem

the anatomical structure may be made using different pod

same or similar manner as that described immediately

blies 82 of the pods 16a -16d to flush and /or prime the system
10 .
[0064 ] While one particular way of operating the system

10 to deliver fluid to an anatomical structure has been

described above , it will be appreciated that the present
disclosure is not intended to be limited solely to this par
ticular way. Rather, the system 10 may be operated in any
number of other suitable ways , each of which remains within

the spirit and scope of the present disclosure. It will be

further appreciated that while the description above was
primarily with respect to pod 16a , the description also

applies to the other pods 166 - 16d with equal force.

[0065 ] As briefly described above , another function that

the system 10 may perform relates to the sensing or mea

suring of one or more parameter ( s ) of interest , or one or

more parameter ( s ) that may be used to derive one or more
parameter ( s ) of interest. For purposes of illustration only , the

description below will be with respect to the sensing or
measuring of electrical resistance or impedance , and , in an
embodiment, the resistance or impedance of an anatomical

structure (e.g., tissue ormuscle ) or particular region thereof

(i. e ., between two pods ), in particular . It will be appreciated ,
however , that the present disclosure is not intended to be

limited solely to the sensing or measuring of impedance ;
rather any number of parameter( s ) may be sensed or mea
sured by the system 10 .
10066 ]. In any event, in an instance wherein the system 10
is configured to sense or measure impedance, the system 10

instance , impedance measurements of different regions of

combinations to make the necessary measurements . In any
event, the electrical connections between the power source

54 or other components in the port 12 and the needles 90 of
one or more pods 16 may be facilitated by one or more

switches 60 that may be controlled by the ECU 52 to couple

the power source 54 and / or impedance measuring/ calculat

ing components to the appropriate needles 90 , and electrical

conductors disposed within the pods 16 , catheter (s ) 14 , and
the port 12 .

[0068 ] Impedance measurements may be used for a vari
ety of purposes . These measurements may be used by a
physician or clinician to evaluate the anatomical structure

being treated in order to determine if and /or how much fluid

should be delivered to the structure or a particular region
thereof. By way of illustration , in an embodiment wherein

botox is the fluid being delivered to one or more particular
regions of an anatomical structure , the resistance or imped

ance of that or those regionsmay be measured in the manner

described above and used to determine or evaluate the

relaxation or paralysis /blockage state of the region , which ,
in turn , may then dictate whether or not and / or how much

botox should be delivered . Accordingly , the impedance of
one or more regions of the anatomical structure may be

measured and the measured value may then be used by the
ECU 52 to automatically make the necessary determinations
as to if botox should be delivered , and if so , how much ( e. g.,
by looking up the measured value in a look - up table or other
data structure that correlates impedance with empirically
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derived botox dosages and/or indications of whether botox

delivery is needed ), or the value (s ) may be communicated
to , and displayed , at the interrogator 18 for a physician or

clinician to view and then , if appropriate , provide commands

to the ECU 52 to cause botox to be delivered to one ormore
regions using one or more pods 16 .
[0069] Impedance measurements may additionally or

alternatively be used to evaluate the operation of the pods
16 , and more particularly , to evaluate whether the needle
assemblies 82 thereof are operating ( e. g ., deploying ) prop
erly or in expected manner. For example, impedance may be
measured in the manner described above and the measured

value may be evaluated to determine whether or not the
deployed properly .More particularly , if an impedance mea

a plurality of drains each of which is in fluid communi

cation with a respective one of the plurality of cham
bers ;
a septum carried by the body and extending across and
overlaying the opening of the body, the septum being

penetrable by a needle to inject fluid into the fluid

reservoir ; and
a connector carried by the body and fluidly coupled to the

plurality of chambers by the plurality of drains ,

wherein the connector is configured to be mated with a
complementary connector of another component of the
fluid delivery system to at least fluidly couple the port
to the other component.

surement is made that exceeds ( or, in an embodiment, meets

2 . The port of claim 1 , wherein each of the plurality of
fluid passageways comprises a one -way valve configured to
allow fluid in the reservoir to flow to corresponding cham

predefined range ( i. e ., is too high to be the impedance of an

ber, and to prevent fluid in the chamber from flowing into the
reservoir.

anatomical structure ), then it may be determined that one or
more of the needles 90 of the needle assemblies 82 of two

fluid delivery system , comprising: a housing including a

needle assemblies 82 of one or more of the pods 16 have

or exceeds ) a predetermined threshold or is outside of a

or more pods 16 is not in contact with the anatomical

structure but rather is in " air,” and thus , did not deploy

3 . An implantable pod adapted for use in an implantable

base having an aperture therein ;

a needle assembly disposed within the housing and com

properly . Measures may then be taken to address the func

prising
a hollow needle having a channel therein configured to

[0070 ] Accordingly, it will be appreciated that impedance
variety of purposes, including, but not limited to , those
described above.
[0071] It is to be understood that the foregoing is a
description of one or more embodiments of the invention .

allow fluid supplied to the needle assembly to flow
a needle actuation mechanism configured to move the

disclosed herein , but rather is defined solely by the claims
below . Furthermore, the statements contained in the forego

a connector carried by the housing and configured to be

ing description relate to particular embodiments and are not

mated with a complementary connector of another
component of the fluid delivery system to at least

to be construed as limitations on the scope of the invention
or on the definition of termsused in the claims, exceptwhere

fluidly couple the pod to the other component; and
one or more fluid passageways disposed within the hous

tionality and operation of that or those particular pod (s ) 16 .

measurements made by the system 10 may be used for a

The invention is not limited to the particular embodiment( s )

a term or phrase is expressly defined above . Various other
embodiments and various changes and modifications to the

disclosed embodiment(s ) will become apparent to those

skilled in the art. All such other embodiments, changes, and
modifications are intended to come within the scope of the
appended claims.
[0072 ] As used in this specification and claims, the terms
" e.g.," " for example," " for instance," " such as,” and “ like,"
and the verbs “ comprising ,” “having ,” “ including," and their
other verb forms, when used in conjunction with a listing of
one or more components or other items, are each to be
construed as open - ended , meaning that the listing is not to

be considered as excluding other, additional components or
items. Other terms are to be construed using their broadest

reasonable meaning unless they are used in a context that
requires a different interpretation .
1 . A port adapted for use in an implantable fluid delivery

system , comprising :
a body including an opening at one end thereof, and
having disposed therein :

a fluid reservoir;

a plurality of chambers ;

a plurality of fluid passageways each configured to fluidly
couple the fluid reservoir with a respective one of the
plurality of chambers ; and

therethrough , and

needle between a retracted state and a deployed state ,

wherein when in the deployed state , at least a portion
of the needle extends through the aperture in the base

of the housing ;

ing to fluidly couple the connector to the needle assem
bly.
4 . A fluid delivery system for delivering fluid to an
anatomical structure of a patient, comprising :

a port having a fluid reservoir and a connector in fluid
communication with the fluid reservoir ;

an implantable pod having a needle assembly comprising
a hollow needle, and

a needle actuation mechanism configured to move the

needle between a retracted state and a deployed state,

and a connector in fluid communication with the needle
a shaft having a first end , a second end opposite the first
assembly ; and a catheter configured comprising

end , and at least one fluid lumen disposed therein
extending between the first and second ends,

a first connector disposed at the first end of the shaft , and

a second connector disposed at the second end of the
shaft ,

wherein one of the first and second connectors is config
ured to be mated with the connector of the port, and the

other of the first and second connectors is configured to
be mated with the connector of the pod so as to at least
fluidly couple the port to the pod .
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